BEGIN:VCALENDAR
VERSION:2.0
PRODID:-// - ECPv6.6.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.biomed.cas.cz
X-WR-CALDESC:Akce na 
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Prague
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Prague:20260415T150000
DTEND;TZID=Europe/Prague:20260415T160000
DTSTAMP:20260415T040334
CREATED:20260408T101152Z
LAST-MODIFIED:20260408T101152Z
UID:2516-1776265200-1776268800@www.biomed.cas.cz
SUMMARY:Seminář Despoina Giamaki
DESCRIPTION:“A hidden layer of chromatin regulation in neurological disease” \nGenome stability and DNA repair are essential for human health. ADP-ribosylation is a key post-translational modification in the DNA damage response\, regulated by PARP enzymes. Our research focuses on ARH3\, an enzyme that removes mono-ADP-ribose from proteins\, as its deficiency is linked to rare neurological disease. Using patient-derived cells\, 3D brain organoids and mouse models\, we show that loss of ARH3 leads to accumulation of mono-ADP-ribose on chromatin. Genome-wide analyses (CUT&Tag\, spatial transcriptomic and RNA-seq) reveal that these changes alter gene expression and modulate other histone modifications. We further explore how these chromatin alterations affect responses to stress\, including viral infections\, potentially contributing to neuropathology. Our findings provide new insights into disease mechanisms and highlight ADP-ribosylation as a potential therapeutic target in neurological disorders.
URL:https://www.biomed.cas.cz/event/seminar-despoina-giamaki/
LOCATION:Posluchárna Milana Haška / Milan Hašek Auditorium
ORGANIZER;CN="%C3%9AMG":MAILTO:leona.krausova@img.cas.cz
END:VEVENT
END:VCALENDAR